Federal Trade Commission v. Watson Pharmaceuticals, Inc.
529 F. App'x 985
Opinion
[986] ON REMAND FROM THE SUPREME COURT OF THE UNITED STATES
The district court’s judgment, which was entered on April 21, 2010, is VACATED, and this case is REMANDED for further proceedings consistent with the Supreme Court’s opinion in F.T.C. v. Actavis, Inc., - U.S. -, 133 S.Ct. 2223, 186 L.Ed.2d 343 (2013).
Free access — add to your briefcase to read the full text and ask questions with AI
Federal Trade Commission v. Watson Pharmaceuticals, Inc., 529 F. App'x 985 (11th Cir. 2013).
529 F. App'x 985 (Federal Trade Commission v. Watson Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
F.T.C. v. Actavis, Inc.
133 S. Ct. 2223 (Supreme Court, 2013)